You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 257 No. 16, April 24, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Cholesterol and Mortality

30 Years of Follow-up From the Framingham Study

Keaven M. Anderson, PhD; William P. Castelli, MD; Daniel Levy, MD

JAMA. 1987;257(16):2176-2180.


Abstract

From 1951 to 1955 serum cholesterol levels were measured in 1959 men and 2415 women aged between 31 and 65 years who were free of cardiovascular disease (CVD) and cancer. Under age 50 years, cholesterol levels are directly related with 30-year overall and CVD mortality; overall death increases 5% and CVD death 9% for each 10 mg/dL. After age 50 years there is no increased overall mortality with either high or low serum cholesterol levels. There is a direct association between falling cholesterol levels over the first 14 years and mortality over the following 18 years (11% overall and 14% CVD death rate increase per 1 mg/dL per year drop in cholesterol levels). Under age 50 years these data suggest that having a very low cholesterol level improves longevity. After age 50 years the association of mortality with cholesterol values is confounded by people whose cholesterol levels are falling—perhaps due to diseases predisposing to death.

(JAMA 1987;257:2176-2180)



Author Affiliations

From the National Heart, Lung, and Blood Institute, Framingham, Mass.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

History of the cholesterol hypothesis in Britain
Grimes
QJM 2009;102:436-438.
FULL TEXT  

Serum Cholesterol LDL and 90-Day Mortality in Patients With Intracerebral Hemorrhage
Ramirez-Moreno et al.
Stroke 2009;40:1917-1920.
ABSTRACT | FULL TEXT  

Coronary artery calcium to predict all-cause mortality in elderly men and women.
Raggi et al.
J Am Coll Cardiol 2008;52:17-23.
ABSTRACT | FULL TEXT  

Baseline Serum Cholesterol Is Selectively Associated With Motor Speed and Not Rates of Cognitive Decline: The Women's Health and Aging Study II
Mielke et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:619-624.
ABSTRACT | FULL TEXT  

Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
Sam et al.
Diabetes Care 2008;31:1237-1241.
ABSTRACT | FULL TEXT  

Interrelation of Coronary Calcification, Myocardial Ischemia, and Outcomes in Patients With Intermediate Likelihood of Coronary Artery Disease: A Combined Positron Emission Tomography/Computed Tomography Study
Schenker et al.
Circulation 2008;117:1693-1700.
ABSTRACT | FULL TEXT  

Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.
Rossi et al.
J Am Coll Cardiol 2008;51:997-1002.
ABSTRACT | FULL TEXT  

Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study
Sritara et al.
ANGIOLOGY 2008;58:757-763.
ABSTRACT  

Impact of Statins on Risk of Stroke: A Meta-Analysis
Henyan et al.
The Annals of Pharmacotherapy 2007;41:1937-1945.
ABSTRACT | FULL TEXT  

Triglycerides and Coronary Heart Disease Revisited (Again)
Criqui
ANN INTERN MED 2007;147:425-427.
FULL TEXT  

Role of the Pharmacist in the Management of Dyslipidemia
Olson and Potts
Journal of Pharmacy Practice 2006;19:94-102.
ABSTRACT  

Dyslipidemia and the Risk of Incident Hypertension in Men
Halperin et al.
Hypertension 2006;47:45-50.
ABSTRACT | FULL TEXT  

The effect of measurement error in risk factors that change over time in cohort studies: do simple methods overcorrect for 'regression dilution'?
Frost and White
Int J Epidemiol 2005;34:1359-1368.
ABSTRACT | FULL TEXT  

Perspectives on Dyslipidemia and Coronary Heart Disease in Women
Bittner
J Am Coll Cardiol 2005;46:1628-1635.
ABSTRACT | FULL TEXT  

Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly
Vliegenthart et al.
Circulation 2005;112:572-577.
ABSTRACT | FULL TEXT  

Low Total Vitamin C Plasma Level Is a Risk Factor for Cardiovascular Morbidity and Mortality in Hemodialysis Patients
Deicher et al.
J. Am. Soc. Nephrol. 2005;16:1811-1818.
ABSTRACT | FULL TEXT  

Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis
Santamarina-Fojo et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:1750-1754.
ABSTRACT | FULL TEXT  

Association Between Cholesterol Level and Mortality in Dialysis Patients: Role of Inflammation and Malnutrition
Liu et al.
JAMA 2004;291:451-459.
ABSTRACT | FULL TEXT  

High cholesterol may protect against infections and atherosclerosis
Ravnskov
QJM 2003;96:927-934.
FULL TEXT  

Effects of Milk Products Fermented by Bifidobacterium longum on Blood Lipids in Rats and Healthy Adult Male Volunteers
Xiao et al.
J DAIRY SCI 2003;86:2452-2461.
ABSTRACT | FULL TEXT  

Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events: A 37-Month Follow-Up of 5635 Initially Asymptomatic Low- to Intermediate-Risk Adults
Kondos et al.
Circulation 2003;107:2571-2576.
ABSTRACT | FULL TEXT  

Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL
Matthan et al.
J. Lipid Res. 2003;44:800-806.
ABSTRACT | FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Statins and stroke: evidence for cholesterol-independent effects
Di Napoli et al.
Eur Heart J 2002;23:1908-1921.
 

Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands
Marang-van de Mheen et al.
Eur Heart J 2002;23:1922-1930.
ABSTRACT  

Coronary atherogenic risk factors in women
Stangl et al.
Eur Heart J 2002;23:1738-1752.
FULL TEXT  

Oxidized Low-Density Lipoprotein Receptor LOX-1 and Apoptosis in Human Atherosclerotic Lesions
Li et al.
J CARDIOVASC PHARMACOL THER 2002;7:147-153.
ABSTRACT  

Understanding the pathophysiology of the arterial wall: which method should we choose? Electron beam computed tomography
Erbell et al.
Eur Heart J Suppl 2002;4:F47-F53.
ABSTRACT  

Reducing cholesterol and atherosclerosis
Hornung
QJM 2002;95:339-341.
FULL TEXT  

Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age
Clarke et al.
Eur Heart J 2002;23:286-293.
ABSTRACT | FULL TEXT  

Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients
Perticone et al.
Circulation 2001;104:191-196.
ABSTRACT | FULL TEXT  

Relationship of Blood Pressure to 25-Year Mortality Due to Coronary Heart Disease, Cardiovascular Diseases, and All Causes in Young Adult Men: The Chicago Heart Association Detection Project in Industry
Miura et al.
Arch Intern Med 2001;161:1501-1508.
ABSTRACT | FULL TEXT  

2000 George Lyman Duff Memorial Lecture : Atherosclerosis Is a Liver Disease of the Heart
Davis and Hui
Arterioscler. Thromb. Vasc. Bio. 2001;21:887-898.
ABSTRACT | FULL TEXT  

An Evidence-Based Assessment of Federal Guidelines for Overweight and Obesity as They Apply to Elderly Persons
Heiat et al.
Arch Intern Med 2001;161:1194-1203.
ABSTRACT | FULL TEXT  

Cost-effectiveness of HMG coenzyme reductase inhibitors. Whom to treat?
van Hout and Simoons
Eur Heart J 2001;22:751-761.
ABSTRACT  

Prediction of sudden cardiac death by fractal analysis of heart rate variability in elderly subjects
Makikallio et al.
J Am Coll Cardiol 2001;37:1395-1402.
ABSTRACT | FULL TEXT  

Age and gender bias in statin trials
Bandyopadhyay et al.
QJM 2001;94:127-132.
ABSTRACT | FULL TEXT  

Distribution of ApoA-I-Containing HDL Subpopulations in Patients With Coronary Heart Disease
Asztalos et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:2670-2676.
ABSTRACT | FULL TEXT  

Use of Simvastatin Treatment in Patients With Combined Hyperlipidemia in Clinical Practice
Vicari et al.
Arch Fam Med 2000;9:898-905.
ABSTRACT | FULL TEXT  

Evaluation of Two Different Homogeneous Assays for LDL-Cholesterol in Lipoprotein-X-positive Serum
Fei et al.
Clin. Chem. 2000;46:1351-1356.
ABSTRACT | FULL TEXT  

Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-term Coronary, Cardiovascular, and All-Cause Mortality and to Longevity
Stamler et al.
JAMA 2000;284:311-318.
ABSTRACT | FULL TEXT  

Early Detection of High Cholesterol Levels in Young Adults
Grundy
JAMA 2000;284:365-367.
FULL TEXT  

Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia
Anderson et al.
Am. J. Clin. Nutr. 2000;71:1433-1438.
ABSTRACT | FULL TEXT  

Age-related Increases in Plasma Phosphatidylcholine Hydroperoxide Concentrations in Control Subjects and Patients with Hyperlipidemia
Kinoshita et al.
Clin. Chem. 2000;46:822-828.
ABSTRACT | FULL TEXT  

Electron-beam computed tomography for detection of early signs of coronary arteriosclerosis
Erbel et al.
Eur Heart J 2000;21:720-732.
 

Efficacy of Atorvastatin Compared With Simvastatin in Patients With Hypercholesterolemia
Farnier et al.
J CARDIOVASC PHARMACOL THER 2000;5:27-32.
ABSTRACT  

Systemic Inflammatory Parameters in Patients With Atherosclerosis of the Coronary and Peripheral Arteries
Erren et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:2355-2363.
ABSTRACT | FULL TEXT  

Primary Prevention of Coronary Heart Disease : Integrating Risk Assessment With Intervention
Grundy
Circulation 1999;100:988-998.
FULL TEXT  

Coronary Heart Disease: Reducing the Risk : The Scientific Background to Primary and Secondary Prevention of Coronary Heart DiseaseA Worldwide View
Assmann et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:1819-1824.
FULL TEXT  

Effects of LY295427, a Low-Density Lipoprotein (LDL) Receptor Up-Regulator, on LDL Receptor Gene Transcription and Cholesterol Metabolism in Normal and Hypercholesterolemic Hamsters
Bensch et al.
J. Pharmacol. Exp. Ther. 1999;289:85-92.
ABSTRACT | FULL TEXT  

Comparison of Cytochrome P-450-Dependent Metabolism and Drug Interactions of the 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Lovastatin and Pravastatin in the Liver
Jacobsen et al.
Drug Metab. Dispos. 1999;27:173-179.
ABSTRACT | FULL TEXT  

Intracellular Translocation and Stability of Apolipoprotein B Are Inversely Proportional to the Length of the Nascent Polypeptide
Cavallo et al.
J. Biol. Chem. 1998;273:33397-33405.
ABSTRACT | FULL TEXT  

Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine
Thorne et al.
J Am Coll Cardiol 1998;32:110-116.
ABSTRACT | FULL TEXT  

Power-Law Relationship of Heart Rate Variability as a Predictor of Mortality in the Elderly
Huikuri et al.
Circulation 1998;97:2031-2036.
ABSTRACT | FULL TEXT  

Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction
Grundy et al.
Circulation 1998;97:1876-1887.
FULL TEXT  

Plasma apolipoproteins A-I and B in survivors of myocardial infarction and in a control group
Graziani et al.
Clin. Chem. 1998;44:134-140.
ABSTRACT | FULL TEXT  

The Munster Heart Study (PROCAM) : Total Mortality in Middle-Aged Men Is Increased at Low Total and LDL Cholesterol Concentrations in Smokers but Not in Nonsmokers
Cullen et al.
Circulation 1997;96:2128-2136.
ABSTRACT | FULL TEXT  

Efficacy and Safety of a New Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitor, Atorvastatin, in Patients with Combined Hyperlipidemia: Comparison with Fenofibrate
Ooi et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1793-1799.
ABSTRACT | FULL TEXT  

Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid Stenosis
Wilson et al.
NEJM 1997;337:516-522.
ABSTRACT | FULL TEXT  

The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
Fisher et al.
J. Biol. Chem. 1997;272:20427-20434.
ABSTRACT | FULL TEXT  

Effect of Serum Lipids, Lipoproteins, and Apolipoproteins on Vascular and Nonvascular Mortality in the Elderly
Raiha et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1224-1232.
ABSTRACT | FULL TEXT  

Influence of Cholesterol Screening and Nutritional Counseling in Reducing Cholesterol Levels in Children
Fitch et al.
CLIN PEDIATR 1997;36:267-272.
ABSTRACT  

National Cholesterol Education Program Recommendations for Cholesterol Testing in Young Adults : A Science-Based Approach
Cleeman and Grundy
Circulation 1997;95:1646-1650.
FULL TEXT  

Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia
Stein et al.
J CARDIOVASC PHARMACOL THER 1997;2:7-16.
ABSTRACT  

Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia
Napoli et al.
J CARDIOVASC PHARMACOL THER 1997;2:17-26.
ABSTRACT  

Human Monocytes/Macrophages Release TNF-{alpha} in Response to Ox-LDL
Jovinge et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:1573-1579.
ABSTRACT | FULL TEXT  

Endothelial Dysfunction Late After Kawasaki Disease
Dhillon et al.
Circulation 1996;94:2103-2106.
ABSTRACT | FULL TEXT  

Coronary Heart Disease Risk Factors in Men and Women Aged 60 Years and Older : Findings From the Systolic Hypertension in the Elderly Program
Frost et al.
Circulation 1996;94:26-34.
ABSTRACT | FULL TEXT  

Survival in the Oldest Old: Death Risk Factors in Old and Very Old Subjects
Dontas et al.
J Aging Health 1996;8:220-237.
ABSTRACT  

Cognitive impairment and mortality in a cohort of elderly people
Gale et al.
BMJ 1996;312:608-611.
ABSTRACT | FULL TEXT  

Estimation of Aortic Wall Sclerosis in Hypertension by Use of Carotid Pulse Tracing and Cine Magnetic Resonance
Honda et al.
ANGIOLOGY 1996;47:157-163.
ABSTRACT  

Evaluating Cholesterol Screening: The Importance of Controlling for Regression to the Mean
Forrow et al.
Arch Intern Med 1995;155:2177-2184.
ABSTRACT  

Low Serum Cholesterol and Mortality : Which Is the Cause and Which Is the Effect?
Iribarren et al.
Circulation 1995;92:2396-2403.
ABSTRACT | FULL TEXT  

Total cholesterol concentration and mortality at a relatively young age: Do men and women differ?
Verschuren and Kromhout
BMJ 1995;311:779-783.
ABSTRACT | FULL TEXT  

Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects
Kuusisto et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1280-1286.
ABSTRACT | FULL TEXT  

HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons
Corti et al.
JAMA 1995;274:539-544.
ABSTRACT  

Serum Total Cholesterol and Mortality: Confounding Factors and Risk Modification in Japanese-American Men
Iribarren et al.
JAMA 1995;273:1926-1932.
ABSTRACT  

Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people
Gale et al.
BMJ 1995;310:1563-1566.
ABSTRACT | FULL TEXT  

Management of Primary Hyperlipidemia
Havel and Rapaport
NEJM 1995;332:1491-1498.
FULL TEXT  

Primary Prevention of Coronary Heart Disease With Drug Therapy: Safety and Total Mortality Issues
Grundy
Arch Intern Med 1992;152:1369-1371.
ABSTRACT  

Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial
Neaton et al.
Arch Intern Med 1992;152:1490-1500.
ABSTRACT  

Plasma Cholesterol Concentration and Mortality: The Whitehall Study
Smith et al.
JAMA 1992;267:70-76.
ABSTRACT  

Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men
Neaton and Wentworth
Arch Intern Med 1992;152:56-64.
ABSTRACT  

Serum Cholesterol as a Prognostic Factor after Myocardial Infarction: The Framingham Study
Wong et al.
ANN INTERN MED 1991;115:687-693.
ABSTRACT  

Comparison of an Aggressive (U.S.) and a Less Aggressive (Canadian) Policy for Cholesterol Screening and Treatment
Krahn et al.
ANN INTERN MED 1991;115:248-255.
ABSTRACT  

What If Americans Ate Less Fat? A Quantitative Estimate of the Effect on Mortality
Browner et al.
JAMA 1991;265:3285-3291.
ABSTRACT  

Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older Americans
Garber et al.
Arch Intern Med 1991;151:1089-1095.
ABSTRACT  

Comparative Study of a Microporous Cholestyramine Analogue (Filicol) and Gemfibrozil for Treatment of Severe Primary Hypercholesterolemia: Short- and Long-term Results
Ros et al.
Arch Intern Med 1991;151:301-305.
ABSTRACT  

Hypercholesterolemia in Elderly Persons: Resolving the Treatment Dilemma
Denke and Grundy
ANN INTERN MED 1990;112:780-792.
ABSTRACT  

Putting Cholesterol Control on a Diet-Reply
Wilson et al.
JAMA 1989;262:2998-2998.
ABSTRACT  

Impact of National Guidelines for Cholesterol Risk Factor Screening: The Framingham Offspring Study
Wilson et al.
JAMA 1989;262:41-44.
ABSTRACT  

Cholesterol Lowering for All: A Closer Look
Palumbo
JAMA 1989;262:91-92.
ABSTRACT  

Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort: The Framingham Heart Study
Levy et al.
ANN INTERN MED 1989;110:101-107.
ABSTRACT  

Cholesterol Reduction and Life Expectancy
FROMMER et al.
ANN INTERN MED 1988;108:313-314.
ABSTRACT  

Cholesterol and Mortality
Hainer
JAMA 1987;258:1608-1609.
ABSTRACT  

Cholesterol Reduction and Life Expectancy
CITKOWITZ
ANN INTERN MED 1987;107:255-256.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.